Axsome Therapeutics Inc (AXSM)

Axsome Therapeutics Inc (AXSM) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $7.6B; returns 1 day -7.1%, 1 week -7.7%, 1 year +14.2%.

Axsome Therapeutics, Inc. (AXSM) is a biopharmaceutical company focused on developing and commercializing novel therapies for central nervous system (CNS) disorders. The company's revenue is primarily generated through the sales of its three commercialized products: Auvelity, Sunosi, and Symbravo.

Groups AXSM belongs to

• Biotechnology
• Biopharmaceutical
• Pharmaceuticals
• CNS Disorders
• Healthcare
• Neuroscience
• Commercial Stage
• Commercial Stage Biotech
• Mental Health Solutions
• Alzheimer's Disease
• Sleep Apnea

AXSM financial model: income statement, cash flow and balance sheet